Publikationen in Zusammenarbeit mit Forschern von Harvard Medical School (3)

2021

  1. A g316a polymorphism in the ornithine decarboxylase gene promoter modulates mycn‐driven childhood neuroblastoma

    Cancers, Vol. 13, Núm. 8

2018

  1. Genomic amplifications and distal 6q loss: Novel markers for poor survival in high-risk neuroblastoma patients

    Journal of the National Cancer Institute, Vol. 110, Núm. 10

2013

  1. Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

    Pediatric Blood and Cancer, Vol. 60, Núm. 3, pp. 363-370